2021 EADV欧洲建议:免疫检查点抑制剂引起的皮肤不良事件的管理

2021-12-15 欧洲皮肤病与性病学会 J Eur Acad Dermatol Venereol

免疫检查点抑制剂(ICIs)的引入开启了肿瘤治疗的新纪元,免疫相关不良事件的发生可能会使ICIs的疗效和安全性方面带来影响。在接受免疫治疗的患者中,约有40%的患者会出现皮肤相关毒性。

中文标题:

2021 EADV欧洲建议:免疫检查点抑制剂引起的皮肤不良事件的管理

英文标题:

European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statement

发布日期:

2021-12-15

简要介绍:

免疫检查点抑制剂(ICIs)的引入开启了肿瘤治疗的新纪元,免疫相关不良事件的发生可能会使ICIs的疗效和安全性方面带来影响。在接受免疫治疗的患者中,约有40%的患者会出现皮肤相关毒性。本文主要针对ICIs引起的皮肤不良事件的管理提供指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 EADV欧洲建议:免疫检查点抑制剂引起的皮肤不良事件的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=8f5341c00229a191, title=2021 EADV欧洲建议:免疫检查点抑制剂引起的皮肤不良事件的管理, enTitle=European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statement, guiderFrom=J Eur Acad Dermatol Venereol, authorId=0, author=, summary=免疫检查点抑制剂(ICIs)的引入开启了肿瘤治疗的新纪元,免疫相关不良事件的发生可能会使ICIs的疗效和安全性方面带来影响。在接受免疫治疗的患者中,约有40%的患者会出现皮肤相关毒性。, cover=https://img.medsci.cn/20211217/1639754312903_1608702.jpg, journalId=0, articlesId=null, associationId=1016, associationName=欧洲皮肤病与性病学会, associationIntro=EADV is a non-profit association, founded in 1987, whose mission is to advance excellence in clinical care, research, education and training in the field of dermatology and Venereology and to act as the advocate and educator of patients particularly those with cutaneous or venereal diseases., copyright=0, guiderPublishedTime=Wed Dec 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">免疫检查点抑制剂(ICIs)的引入开启了肿瘤治疗的新纪元,免疫相关不良事件的发生可能会使ICIs的疗效和安全性方面带来影响。在接受免疫治疗的患者中,约有40%的患者会出现皮肤相关毒性。本文主要针对ICIs引起的皮肤不良事件的管理提供指导建议。</span></p>, tagList=[TagDto(tagId=36163, tagName=免疫检查点抑制剂), TagDto(tagId=43506, tagName=皮肤病理), TagDto(tagId=50315, tagName=皮肤不良事件)], categoryList=[CategoryDto(categoryId=39, categoryName=皮肤性病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=50315, guiderKeyword=皮肤不良事件, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1694, appHits=55, showAppHits=0, pcHits=260, showPcHits=1639, likes=0, shares=6, comments=3, approvalStatus=1, publishedTime=Fri Dec 17 23:15:58 CST 2021, publishedTimeString=2021-12-15, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Fri Dec 17 23:23:49 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Fri Jan 05 22:08:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 EADV欧洲建议:免疫检查点抑制剂引起的皮肤不良事件的管理.pdf)])
2021 EADV欧洲建议:免疫检查点抑制剂引起的皮肤不良事件的管理.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1249548, encodeId=c1671249548b4, content=<a href='/topic/show?id=0de5290588c' target=_blank style='color:#2F92EE;'>#免疫检查点抑制剂#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29058, encryptionId=0de5290588c, topicName=免疫检查点抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Sat Sep 17 06:48:40 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082494, encodeId=8a9410824941a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28725559377, createdName=ms9000001978178085, createdTime=Tue Dec 21 10:11:12 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1249548, encodeId=c1671249548b4, content=<a href='/topic/show?id=0de5290588c' target=_blank style='color:#2F92EE;'>#免疫检查点抑制剂#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29058, encryptionId=0de5290588c, topicName=免疫检查点抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Sat Sep 17 06:48:40 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082494, encodeId=8a9410824941a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28725559377, createdName=ms9000001978178085, createdTime=Tue Dec 21 10:11:12 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2021-12-21 ms9000001978178085

    学习了

    0